SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from ClearPoint Neuro, (CLPT) — Jan 20, 2026

ClearPoint Neuro, Inc.
Date: Jan. 20, 2026 · CIK: 0001285550 · Accession: 0001683168-26-000424

Offering / Registration Process Regulatory Compliance

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-292733

Date
January 20, 2026
Author
Ellisa Cholapranee
Form
CORRESP
Company
ClearPoint Neuro, Inc.

Letter

CLEARPOINT NEURO, INC.

120 S. Sierra Ave., Suite 100

Solana Beach, California 92075

January 20, 2026

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Robert Augustin

Re: ClearPoint Neuro, Inc.

Registration Statement on Form S-3

Originally Filed January 14, 2026

File No. 333-292733

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the "Act"), ClearPoint Neuro, Inc. (the "Company") respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Thursday, January 22, 2026, or as soon thereafter as possible. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.

Please notify John Tishler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (858) 720-8943 as soon as possible as to the time the registration statement has been declared effective pursuant to this acceleration request.

Very truly yours,
CLEARPOINT NEURO, INC.

Show Raw Text
CORRESP
 1
 filename1.htm

 CLEARPOINT NEURO, INC.

 120 S. Sierra Ave., Suite 100

 Solana Beach, California 92075

 January 20, 2026

 VIA EDGAR

 United States Securities and Exchange Commission

 Division of Corporation Finance

 100 F Street, N.E.

 Washington, D.C. 20549

 Attn: Robert Augustin

 Re: ClearPoint Neuro, Inc.

 Registration Statement on Form S-3

 Originally Filed January 14, 2026

 File No. 333-292733

 Ladies and Gentlemen:

 Pursuant to Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended (the "Act"), ClearPoint Neuro, Inc.
(the "Company") respectfully requests that the effective date of the registration statement referred to above be accelerated
so that it will become effective at 5:00 p.m., Eastern Standard Time, on Thursday, January 22, 2026, or as soon thereafter as possible. In
making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.

 Please notify John Tishler
of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (858) 720-8943 as soon as possible as to the time the registration
statement has been declared effective pursuant to this acceleration request.

 Very truly yours,

 CLEARPOINT NEURO, INC.

 By:
 /s/ Ellisa Cholapranee

 Name:
 Ellisa Cholapranee

 Title:
 General Counsel

 cc: John Tishler, Sheppard, Mullin, Richter & Hampton LLP